Literature DB >> 21350576

Atrial fibrillation: therapy with omega-3 fatty acids-is the case closed?

Stanley Nattel, David R Van Wagoner.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21350576     DOI： 10.1038/nrcardio.2011.11

Source DB:  PubMed          Journal:  Nat Rev Cardiol        ISSN： 1759-5002            Impact factor:   32.419


× No keyword cloud information.
  10 in total

1.  Efficacy and safety of prescription omega-3 fatty acids for the prevention of recurrent symptomatic atrial fibrillation: a randomized controlled trial.

Authors:  Peter R Kowey; James A Reiffel; Kenneth A Ellenbogen; Gerald V Naccarelli; Craig M Pratt
Journal:  JAMA       Date:  2010-11-15       Impact factor: 56.272

Review 2.  New ideas about atrial fibrillation 50 years on.

Authors:  Stanley Nattel
Journal:  Nature       Date:  2002-01-10       Impact factor: 49.962

Review 3.  Atrial remodeling and atrial fibrillation: mechanisms and implications.

Authors:  Stanley Nattel; Brett Burstein; Dobromir Dobrev
Journal:  Circ Arrhythm Electrophysiol       Date:  2008-04

4.  n-3 polyunsaturated fatty acids for the prevention of arrhythmia recurrence after electrical cardioversion of chronic persistent atrial fibrillation: a randomized, double-blind, multicentre study.

Authors:  Leopoldo Bianconi; Leonardo Calò; Mauro Mennuni; Luca Santini; Paolo Morosetti; Paolo Azzolini; Giuseppe Barbato; Francesco Biscione; Paolo Romano; Massimo Santini
Journal:  Europace       Date:  2010-11-08       Impact factor: 5.214

5.  Electropathological substrate of long-standing persistent atrial fibrillation in patients with structural heart disease: longitudinal dissociation.

Authors:  Maurits A Allessie; Natasja M S de Groot; Richard P M Houben; Ulrich Schotten; Eric Boersma; Joep L Smeets; Harry J Crijns
Journal:  Circ Arrhythm Electrophysiol       Date:  2010-08-18

Review 6.  Novel approaches for pharmacological management of atrial fibrillation.

Authors:  Joachim R Ehrlich; Stanley Nattel
Journal:  Drugs       Date:  2009       Impact factor: 9.546

7.  Changes in connexin expression and the atrial fibrillation substrate in congestive heart failure.

Authors:  Brett Burstein; Philippe Comtois; Georghia Michael; Kunihiro Nishida; Louis Villeneuve; Yung-Hsin Yeh; Stanley Nattel
Journal:  Circ Res       Date:  2009-10-29       Impact factor: 17.367

8.  Does treatment with n-3 polyunsaturated fatty acids prevent atrial fibrillation after open heart surgery?

Authors:  Ragnhildur Heidarsdottir; David O Arnar; Gudrun V Skuladottir; Bjarni Torfason; Vidar Edvardsson; Gizur Gottskalksson; Runolfur Palsson; Olafur S Indridason
Journal:  Europace       Date:  2010-01-07       Impact factor: 5.214

9.  Omega-3 fatty acid supplementation does not reduce risk of atrial fibrillation after coronary artery bypass surgery: a randomized, double-blind, placebo-controlled clinical trial.

Authors:  Palaniappan Saravanan; Ben Bridgewater; Annette L West; Stephen C O'Neill; Philip C Calder; Neil C Davidson
Journal:  Circ Arrhythm Electrophysiol       Date:  2009-12-30

Review 10.  Impact of dietary fatty acids on cardiac arrhythmogenesis.

Authors:  Julie H Rennison; David R Van Wagoner
Journal:  Circ Arrhythm Electrophysiol       Date:  2009-08
  10 in total
  2 in total

1.  Fish oil for atrial fibrillation prevention: can we intervene soon enough to make a difference?

Authors:  David R Van Wagoner
Journal:  Heart Rhythm       Date:  2012-03-07       Impact factor: 6.343

2.  Fish, Marine n-3 Fatty Acids, and Atrial Fibrillation - Experimental Data and Clinical Effects.

Authors:  Thomas Andersen Rix; Lotte Maxild Mortensen; Erik Berg Schmidt
Journal:  Front Physiol       Date:  2012-05-25       Impact factor: 4.566
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.